Intervest — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Genkore develops ultra-compact gene-editing technology to create therapeutic treatments for neurodegenerative diseases such as Huntington's and ALS.
BiotechDeep TechMedical DevicesSeoul, KR
Kim Yong-sam
Co-investorsAju IB InvestmentKiwoom Investment
Korean aesthetic-medicine platform, operated by Healing Paper, connecting users with clinics for treatment information and bookings.
Co-investorsAtinum Investment Co. Ltd.Kiwoom InvestmentKT investment Inc.KT Strategic Investment Fund 4Aju IB InvestmentDSC Investment+4 more
MADDE provides 3D printing-based manufacturing services using silicon carbide (SiC) and metal materials, producing components for high-value industries including semiconductors, space, nuclear, and defense.
Advanced ManufacturingHardwareNew Materials
Co-investorsAtinum Investment Co. Ltd.Company K PartnersDSC InvestmentSchmidt
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
